Profile
Getwell Life Sciences India Pvt. Ltd. is an upcoming, professionally managed pharmaceutical company promoted by technocrats with vast experience in the field of drugs & pharmaceuticals. Currently the companies operations are focused in the field of Oncology.

GETWELL has achieved prominence in the Indian pharmaceutical industry within a short time with a comprehensive product-range in oncology. Today the company is well known for manufacturing and marketing of anti cancer drugs used in cancer chemotherapy as well as drugs used for supportive-care in oncology.

GETWELL, possesses extensive experience in handling oncology products. The company has been manufacturing anti cancer formulations for some of the leading pharmaceutical companies in India for the past many years. The GLS products are also under various stages of registration in the offshore markets.

Getwell Life Science's Board
The GLS operations are headed by CEO and Director, Mr. Suresh Pathak . The other members on the board bring in their rich experience in production, finance, & business planning.

Mr. Suresh Pathak
Mr. Pathak has been in the field of pharmaceuticals for more than 30 years and has an impressive track-record. He has held several senior level national and international assignments in leading pharmaceutical companies. Prior to moving over to GLS, he was Vice President - S&M with Zydus Cadila. Mr.Pathak's exemplary leadership was instrumental in the meteoric rise of Dabur Pharma Ltd. during his stint of over 8 years as Strategic Business Unit Head.

A pharmacy & management honours graduate from B.I.T.S Pilani, Mr. Pathak is widely known in the industry for giving a new thrust to the Oncology market in India. An adequate exposure to international market in terms of regulatory affairs ,new product launches, and business development through foreign collaborations and in-licensing , make him an ideal leader for the high aspirations of GLS.

Currently Mr Pathak is also on the board of Sai Phytoceuticals Pvt Ltd a specialty API company making anticancer molecules ( www.saiphyto.com )


Mr. Rajiv Tandon
A post graduate in pharmacy from B.I.T.S Pilani, Mr. Tandon started his career with Ranbaxy. Within Ranbaxy Mr. Tandon worked with production and R&D departments. He later moved to the public sector giant IDPL. A wide exposure, expertise in parenteral dosage forms and a strong production management background in such large corporations propelled him towards entrepreneurship early in life. He started with the manufacturing unit of Getwell Pharmaceuticals at Gurgaon in 1989. Under the leadership of Mr. Rajiv Tandon, Getwell has been a trusted contract manufacturer for many years for pharma majors like Cipla, Cadila Pharma and Dabur.









Mr. Rajiv Nath Rekhi
A well known figure in the real estate business of the National Capital Region of Delhi, Mr. Rekhi belongs to a family of pioneers in hotel industry in Delhi. Mr.Rekhi is a post graduate in economics from Delhi School of Economics and possesses postgraduate management qualification from Asian Institute of Management, Philippines. The company's finance operations are immensely benefited with Mr. Rekhi's foresight and investment skills.

Further augmentation of the board is planned for the near future. Some eminent personalities from the field of pharmaceuticals and healthcare are likely to strengthen the GLS' board.








Performance
A steady sales growth of Getwell Life Sciences India Pvt. Ltd. over the past two years have put the company at the forefront of the Oncology market in India.The company touched a turnover of Rs.8 crores in the second year of operations with a PAT exceeding 10 %. In the third FY the company is poised to touch the Rs.15 crore mark . This has been possible largely due to its people resource. The commitment, dedication and quality of GLS fieldforce has become a benchmark in the Oncology market. The standard of scientific promotion and training imparted to executives and managers can be rated as one of the best in the industry. Today, products of GLS are available in every corner of the country with extreme caution exercised in the maintenance of cold-chain. With 14 branches and 400 authorized distributors across the country the company can boast of a highly efficient distribution network, spreading far and wide even to the remote markets.